PER-100-03已完成未知
RANDOMIZED STUDY OF COADYUVANT CHEMOTHERAPY WITH STANDARD REGIMES OF CYCLOPHOSPHAMIDE, METHOTREXATE AND FLUORURACILO - (CMF) OR DOXORUBICINE AND CICLOFOSFAMIDA - (AC) VERSUS CAPECITABINE IN WOMEN 65 YEARS OF AGE OR MORE POSITIVE OR NEGATIVE NODULES WITH HIGH-RISK BREAST CANCER.
EASTERN COOPERATIVE ONCOLOGY GROUP (ECOG),0 个研究点目标入组 0 人开始时间: 2004年2月6日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 0 至 0（—）
入选标准
- •Patients with operable, histologically confirmad adenocarcinoma of the female breast.
- •STNM Stage: T1-3, N1. MO or T2, NO, MO if a primary lesion > 3 cm.
- •or T3. NO. MO
- •Age 65 years or older
- •Performance status 0-2 (Common Toxicity Criteria).
排除标准
- 未提供
研究者
相似试验
招募中
不适用
Randomized study of neoadjvant chemotherapy with FAP versus DCF in patients with resectable Esophageal cancerJPRN-UMIN000004555Department of Gastroenterologial Surgery, Graduate School of Medicine,Osaka University160
尚未招募
2 期
A STUDY OF CHEMOTHERAPY FOLLOWED BY RADIOTHERAPY IN BORDERLINE RESECTABLE PANCREATIC CANCER(BRPC) AND LOCALLY ADVANCED PANCREATIC CANCER (LAPC)CTRI/2021/10/037538PGIMER CHANDIGARH
已完成
2 期
A phase II study of combination chemotherapy with carboplatin plus S-1 in advanced lung squamous cell carcinomaung cancerJPRN-UMIN000006983Hamamatsu University School of Medicine50
已完成
2 期
A phase II study of combination chemotherapy with carboplatin plus S-1 in advanced and recurrence non small cell lung cancernon-small-cell lung cancerJPRN-UMIN000010189ational Hospital Organization Osaka20
已完成
2 期
A Phase II study of combination chemotherapy with TS-1 and Trastuzumab for patients with HER2 positive advanced or recurrent gastric cancer.advanced or recurrent gastric cancerJPRN-UMIN000008220Osaka medical center for cancer and cardiovascular diseases20